We have just completed the latest data update to BiomarkerBase, which includes the following new information:

  • 3,199 Biomarkers (unique Target/Disease combinations)

  • 10,224 Clinical Trials
  • 9 Diseases

As we mentioned in our last product update post, this is the second of a few product updates in October. That brings the grand total in October to:

  • 5,459 new clinically validated biomarkers
  • 119 new Targets
  • 59 new Diseases
  • 52 new Drugs
  • 10,421 new Clinical Trials

Those of you subscribed to BiomarkerBase with items that you are “Watching” should have received update digest emails outlining the additions resulting from the update. There’s no better way to stay on top of a changing clinical landscape.

Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access